Form 4: Roivant Sciences Executive Eric Venker Exercises Options and Sells Shares

Roivant Sciences' President & COO, Eric Venker, executed stock options and sold a portion of the acquired shares, as detailed in a recent SEC filing.

Summary

• Eric Venker, President & COO of Roivant Sciences Ltd., engaged in transactions involving Roivant's common shares.
• On February 12, 2025, Venker exercised options to acquire 300,000 common shares at a price of $3.85 per share and sold 217,384 shares at a weighted average price of $10.53.
• Following these transactions, Venker directly held 732,294 common shares.
• On February 13, 2025, Venker again exercised options to acquire 300,000 common shares at $3.85 and sold 218,041 shares at a weighted average price of $10.42.
• After the second set of transactions, Venker directly held 896,869 common shares.
• Venker also holds 11,026,234 stock options.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing detailing insider transactions, which is neutral in sentiment.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the trading activities of company executives.

Stakeholder Impact

• The transactions may have a minor impact on shareholders due to the increased supply of shares in the market.

Key Dates

Keywords

Roivant Sciences, Eric Venker, stock options, common shares, SEC Form 4, insider trading, executive compensation